Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 12 Brain Neoplasms 8 Breast Neoplasms 5 Agnosia 4 Thyroid Neoplasms 3 Stomach Neoplasms 3 Lung Neoplasms 3 Emergence Delirium 3 Colorectal Neoplasms 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Pain 2 Inflammation 2 Dexmedetomidine 2 Delirium 2 Chronic Pain 2 Thrombosis 1 Supratentorial Neoplasms 1 Sigmoid Neoplasms 1 Sedation 1 Sarcoma 1 Retinoblastoma 1 Rectal Neoplasms 1 Prostatic Hyperplasia 1 Postoperative Nausea and Vomiting 1 Pneumoperitoneum 1 Pheochromocytoma 1 Opioid Consumption, Postoperative 1 Neoplasms 1 Neoplasm Metastasis 1

Interventions

salicylhydroxamic acid 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 edoxaban 1 apixaban 1 X-Rays 1 Warfarin 1 Technetium Tc 99m Sulfur Colloid 1 Saline Solution 1 Rivaroxaban 1 Radiotherapy, Conformal 1 Physical Therapy Modalities 1 Photons 1 Paclitaxel 1 Musculoskeletal Manipulations 1 Fondaparinux 1 Enoxaparin 1 Docetaxel 1 Dexmedetomidine 1 Dalteparin 1 Dabigatran 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Thrombosis × Dexmedetomidine × Clear all

NCT06993740 2025-06-15

DEXFLAP

Dharmais National Cancer Center Hospital

Phase NA Recruiting

Inflammation, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡